Think Again, Think Ahead: Euronet Worldwide, Inc. (EEFT), Medtronic plc (MDT)

Over the past 52 weeks, the shares of Euronet Worldwide, Inc. (NASDAQ:EEFT) has been trading as low as $70.67 before witnessing a massive surge by 98.77% or $69.8. This price movement has led to the EEFT stock receiving more attention and has become one to watch out for. It jumped by 1.23% on Thursday and this got the market excited. The stock’s beta now stands at 1.27 and when compared to its 200-day moving average and its 50-day moving average, EEFT price stands 34.03% above and 16.48% above respectively. Its average daily volatility for this week is 1.99% which is more than the 1.81% recorded over the past month. The shares of Euronet Worldwide, Inc. advanced by 0.64% or -$-0.89 from its last recorded high of $139.58 which it attained on March 14 to close at $140.47 per share.

Euronet Worldwide, Inc. (EEFT) rose 2.94% this week, a trend that has led to both investors and traders taking note of the stock. Over the past one year, the equity price has embarked on a rally that has seen it rise 61.39% and is now up by 37.2% since start of this year. A look at its monthly performance shows that the stock has recorded a 9.09% gain over the past 30 days. Its equity price climbed by 24.12% over the past three months which led to its overall six-month increase to stand at 40.53%.

Experts from research firms are bullish about the near-term performance of Euronet Worldwide, Inc. with most of them predicting a $148.11 price target on a short-term (12 months) basis. The average price target by the analysts will see a 5.44% rise in the stock and would lead to EEFT’s market cap to surge to $7.73B. The stock has been rated an average 0, which roughly stands towards the bullish end of the spectrum. Reuters looked into the 10 analysts that track Euronet Worldwide, Inc. (NASDAQ:EEFT) and find out that 1 of them rated it as a Hold. 9 of the 9 analysts rated it as a Buy or a Strong Buy while 0 advised investors to desist from buying the stock or sell it if they already possess it.

A look at EEFT technical analysis shows that its 14-day Relative Strength Index (RSI) is in a overbought zone after reaching 82.78 point. Its trading volume has added 1595807 shares compared to readings over the past three months as it recently exchanged 2061477 shares. This means there is improved activity from short-term traders as per session, its average trading volume is 465670 shares, and this is 4.43 times the normal volume.

The price of Medtronic plc (NYSE:MDT) currently stands at $93.33 after it went up by $0.31 or 0.33% and has found a strong support at $92.67 a share. If the MDT price drops below that critical support, then it would lead to a bearish trend. In the short-term, a dip below the $92.01 mark would also be bad for the stock as it means that the stock would plunge by 1.41% from its current position. However, if the stock price is able to trade above the resistance point around $93.76, then it could likely surge higher to try and break the upward resistance which stands at $94.19 a share. Its average daily volatility over the past one month stands at 1.32%. The stock has plunged by 0.95% from its 52-weeks high of $92.44 which it reached on Sep. 26, 2018. In general, it is 18.13% above its 52-weeks lowest point which stands at $76.41 and this setback was observed on Mar. 23, 2018.

Analysts have predicted a price target for Medtronic plc (MDT) for 1 year and it stands at an average $103.56/share. This means that it would likely increase by 10.96% from its current position. The current price of the stock has been moving between $92.44 and $93.5299. Some brokerage firms have a lower target for the stock than the average, with one of them setting a price target as low as $84. On the other hand, one analyst is super bullish about the price, setting a target as high as $121.

Analysts view Medtronic plc (NYSE:MDT) as a Hold, with 2.2 consensus rating. Reuters surveyed 29 analysts that follow MDT and found that 11 of those analysts rated the stock as a Hold. The remaining 18 were divided, with 18 analyst rating it as a Buy or a Strong Buy while 0 analysts advised investors to desist from buying Medtronic plc (MDT) shares or sell it if they already own it.